Impact of the COVID-19 pandemic on England’s national prescriptions of oral vitamin K antagonist (VKA) and direct-acting oral anticoagulants (DOACs): An interrupted time series analysis (January 2019 - February 2021)

Sajidah Alkhameys, Ravina Barrett

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Impact of the COVID-19 pandemic on England’s national prescriptions of oral vitamin K antagonist (VKA) and direct-acting oral anticoagulants (DOACs): An interrupted time series analysis (January 2019 - February 2021)'. Together they form a unique fingerprint.

Medicine & Life Sciences